Spiracur's portable wound therapy device CE marked
This article was originally published in Clinica
Executive Summary
Spiracur has CE marked its "ultraportable" SNaP wound care system for sale in Europe. The single-use negative pressure device removes small amounts of fluid from ulcers, surgically closed incisions, and chronic, acute, traumatic, subacute and dehisced wounds. SNaP does not use electricity or battery power, instead using "spring and piston technology" to create a constant negative pressure, making it "completely silent", according to Sunnyvale, California-based Spiracur. It is also small enough to fit easily under a patient's clothing, and weighs less than 85g. The firm believes that smaller, more discreet devices can improve patient compliance and improve their quality of life. SNaP was cleared by the US FDA in August 2009 in a new therapy category known as "non-powered" NPWT devices.